Viewing Study NCT02704858


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2026-01-02 @ 6:20 AM
Study NCT ID: NCT02704858
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2016-01-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
Sponsor: Neonc Technologies, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module